定位手術装置市場 - 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、用途別、地域別、競合別、2020年～2030年

定位手術装置の世界市場規模は2024年に251億8,000万米ドルとなり、予測期間中のCAGRは5.53%で2030年には347億8,000万米ドルに達すると予測されています。

定位手術は、体内の特定部位（典型的には脳）を極めて正確に標的にする高精度の医療処置です。診断と治療の両方の目的で使用されることが多く、特殊な画像技術、コンピューターによる3D座標、精密な器具が用いられます。定位手術の目的は、周囲の健康な組織へのダメージを最小限に抑えながら、狙った部位に正確にアクセスして治療することです。

標的部位へのアクセスには、特殊な手術器具が使用されます。これらの器具にはプローブ、電極、針などがあり、小さな切開創から挿入され、体内の正確な位置に到達します。定位手術は、てんかん発作の発生源を突き止め、治療するために用いられます。これには、てんかん発作の焦点の除去や、異常な電気活動を制御する装置の埋め込みなどが含まれます。三叉神経痛のようなある種の慢性疼痛は、疼痛の原因となる神経経路を正確に標的にすることで治療できます。

パーキンソン病、てんかん、本態性振戦、脳腫瘍などの神経疾患の増加により、先進的な定位手術装置の需要が高まっています。GLOBOCANが提供した最近のデータによると、2022年に世界で新たに発生した脳・中枢神経系がんの推定症例数は人口10万人当たり32万2,000人であり、2045年には人口10万人当たり47万4,000人に増加すると予測されています。

これらの疾患の正確で的を絞った治療には、これらの機器が不可欠です。画像技術、ロボット工学、ナビゲーションシステムの進歩により、定位手術の精度、正確さ、安全性が向上しています。これらの技術は進化を続け、定位手術装置の能力を高め、医療従事者と患者の双方を魅了しています。患者やヘルスケアプロバイダーは、患者の外傷の軽減、回復時間の短縮、治療成績の向上により、低侵襲治療の選択肢を求めるようになってきています。定位手術装置は、従来はより侵襲的な方法で治療されていた疾患に対して、より低侵襲な処置を可能にします。

主要な市場促進要因

神経疾患の増加

主要な市場課題

合併症のリスク

主要市場動向

共同研究開発

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の定位手術装置市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（ガンマナイフ、LINAC、PBRT、サイバーナイフ）
  • 用途別（肝臓、乳房、前立腺、肺、結腸、その他）
  • 企業別（2024年）
  • 地域別
• 市場マップ

第6章 北米の定位手術装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の定位手術装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の定位手術装置市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の定位手術装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの定位手術装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • UAE

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Siemens AG
• Elekta AB
• Varian Medical Systems, Inc.
• IBA Group Inc.
• Accuray Incorporated
• Koninklijke Philips N.V.
• Hitachi Medical Systems
• Huiheng Group
• Ion Beam Applications S.A.
• inomed Medizintechnik GmbH

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Stereotactic Surgery Devices Market was valued at USD 25.18 Billion in 2024 and is expected to reach USD 34.78 Billion by 2030 with a CAGR of 5.53% during the forecast period.

Stereotactic surgery is a highly precise medical procedure that involves targeting specific areas within the body, typically the brain, with the utmost accuracy. It is often used for both diagnostic and therapeutic purposes, involving the use of specialized imaging techniques, computerized 3D coordinates, and precise instruments. The goal of stereotactic surgery is to minimize damage to surrounding healthy tissues while accurately accessing and treating the targeted area.

Specialized surgical instruments are used to access the target area. These instruments may include probes, electrodes, or needles that are inserted through small incisions to reach the precise location within the body. Stereotactic procedures can be used to locate and treat the source of epileptic seizures. This may involve removing the seizure focus or implanting devices that can control abnormal electrical activity. Certain types of chronic pain, like trigeminal neuralgia, can be treated by precisely targeting the nerve pathways responsible for the pain.

The increasing incidence of neurological disorders such as Parkinson's disease, epilepsy, essential tremors, and brain tumors has driven the demand for advanced stereotactic surgery devices. According to the recent data provided by the GLOBOCAN, in 2022, globally the estimated new cases of brain and central nervous system cancer was estimated to be 322,000 per 100,000 population and the projection were estimated to increase 474,000 per 100,000 population by 2045.

These devices are crucial for accurate and targeted treatment of these conditions. Advances in imaging technologies, robotics, and navigation systems have led to improved accuracy, precision, and safety in stereotactic procedures. As these technologies continue to evolve, they enhance the capabilities of stereotactic surgery devices, attracting both healthcare professionals and patients. Patients and healthcare providers are increasingly seeking minimally invasive treatment options due to reduced patient trauma, shorter recovery times, and improved outcomes. Stereotactic surgery devices enable less invasive procedures for conditions that were traditionally treated through more invasive methods.

Key Market Drivers

Increasing Neurological Disorders

Neurological disorders are a group of medical conditions that affect the nervous system, which includes the brain, spinal cord, and peripheral nerves. These disorders can lead to a wide range of symptoms and challenges that affect a person's cognitive, sensory, motor, and autonomic functions. Neurological disorders can have various causes, including genetic factors, environmental influences, infections, injuries, autoimmune responses, and degenerative processes. Alzheimer's Disease is a progressive neurodegenerative disorder that primarily affects memory, cognition, and behavior. It is the most common cause of dementia in older adults. Parkinson's Disease is a chronic disorder that affects movement and often causes tremors, rigidity, and difficulty with balance and coordination due to a loss of dopamine-producing brain cells. Additionally, as per the recent data provided by the World Health Organization (2024), epilepsy affects approximately 50 million people worldwide, making it one of the most prevalent neurological disorders globally. Nearly 80% of those affected reside in low- and middle-income countries.

Multiple Sclerosis (MS) is an autoimmune disorder in which the immune system attacks the protective covering of nerve fibers, leading to communication problems between the brain and the rest of the body. Stroke is a sudden interruption of blood supply to the brain, either due to a blood clot (ischemic stroke) or bleeding in the brain (hemorrhagic stroke). Strokes can lead to a range of neurological deficits. Migraine is a type of severe headache often accompanied by other symptoms such as nausea, sensitivity to light and sound, and visual disturbances. Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and eventual loss of motor function. Huntington's Disease is an inherited disorder that causes progressive brain cell degeneration, leading to motor abnormalities, cognitive decline, and psychiatric symptoms.

Key Market Challenges

Risk of Complications

Stereotactic procedures, while offering precise targeting and minimally invasive approaches, are not without potential risks and complications. These challenges need to be carefully managed to ensure patient safety and the successful outcomes of procedures. Like any surgical procedure, stereotactic surgeries carry inherent risks such as bleeding, infection, anesthesia complications, and damage to surrounding tissues. Minimizing these risks requires meticulous surgical technique and adherence to sterile procedures. Stereotactic surgeries often involve procedures on the brain or nervous system, which can lead to potential neurological complications such as seizures, nerve damage, or changes in cognitive function. Despite advanced imaging and targeting systems, there is a risk of misalignment or inaccuracy in targeting the intended site. This can lead to unintended tissue damage or incomplete treatment. The devices used in stereotactic surgeries, including robotic systems, navigation tools, and imaging equipment, can malfunction. Device failures can impact the accuracy and safety of the procedure. Surgical site infections can lead to prolonged recovery times, additional medical interventions, and increased healthcare costs. Infections can result from improper sterile techniques, inadequate wound care, or patient-related factors. After the procedure, patients can experience complications such as swelling, pain, cerebrospinal fluid leaks, or hematomas. Monitoring and managing these complications are essential for patient recovery. Patients' individual health conditions, anatomy, and medical history can impact the risk of complications. Preoperative assessments and careful patient selection are crucial to minimizing these risks.

Key Market Trends

Collaborative Research and Development

Collaborative efforts between medical device manufacturers, research institutions, healthcare providers, and other stakeholders play a significant role in advancing the field of stereotactic surgery devices. Collaborations bring together diverse expertise from various fields such as engineering, medicine, and imaging technology. This cross-disciplinary approach fosters innovation, leading to the development of more advanced and effective stereotactic surgery devices. Collaborative R&D allows organizations to pool resources, including financial investments, research facilities, and personnel. This can expedite the development process and help bring new devices to the market faster. Research institutions and universities often have experts in specialized areas, such as imaging technology or neuroscience. Collaborating with these experts provides medical device companies with access to specialized knowledge and insights. Healthcare providers and medical institutions can collaborate in clinical trials and studies to validate the safety and efficacy of new stereotactic surgery devices. This validation is crucial for regulatory approvals and market acceptance. Involving healthcare professionals, including surgeons and nurses, in the design and development process ensures that the devices are user-friendly, efficient, and aligned with clinical needs. Collaborations often involve partners from different regions and countries, providing a global perspective on challenges and opportunities in the stereotactic surgery devices market. Many advanced stereotactic surgery devices require ongoing research and iterative development. Collaborative efforts ensure that devices evolve to meet changing patients' needs and technological advancements.

Key Market Players

• Siemens AG
• Elekta AB
• Varian Medical Systems, Inc.
• IBA Group Inc.
• Accuray Incorporated
• Koninklijke Philips N.V.
• Hitachi Medical Systems
• Huiheng Group
• Ion Beam Applications S.A.
• inomed Medizintechnik GmbH

Report Scope:

In this report, the Global Stereotactic Surgery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Stereotactic Surgery Devices Market, By product Type:

• Amma Knife
• LINAC
• PBRT
• CyberKnife

Stereotactic Surgery Devices Market, By Application:

• Liver
• Breast
• Prostate
• Lung
• Colon
• Others

Stereotactic Surgery Devices Market, By region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Stereotactic Surgery Devices Market.

Available Customizations:

Global Stereotactic Surgery Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Stereotactic Surgery Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Gamma Knife, LINAC, PBRT, CyberKnife)
  • 5.2.2. By Application (Liver, Breast, Prostate, Lung, Colon, Others)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Stereotactic Surgery Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Stereotactic Surgery Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Stereotactic Surgery Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Stereotactic Surgery Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application

7. Europe Stereotactic Surgery Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Stereotactic Surgery Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Stereotactic Surgery Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Stereotactic Surgery Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Stereotactic Surgery Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Stereotactic Surgery Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Stereotactic Surgery Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Stereotactic Surgery Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Stereotactic Surgery Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Stereotactic Surgery Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Stereotactic Surgery Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Stereotactic Surgery Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application

9. South America Stereotactic Surgery Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Stereotactic Surgery Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Stereotactic Surgery Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Stereotactic Surgery Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Stereotactic Surgery Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Stereotactic Surgery Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Stereotactic Surgery Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Stereotactic Surgery Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Siemens AG
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (In case of listed companies)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Elekta AB
• 15.3. Varian Medical Systems, Inc.
• 15.4. IBA Group Inc.
• 15.5. Accuray Incorporated
• 15.6. Koninklijke Philips N.V.
• 15.7. Hitachi Medical Systems
• 15.8. Huiheng Group
• 15.9. Ion Beam Applications S.A.
• 15.10. inomed Medizintechnik GmbH

16. Strategic Recommendations

17. About Us & Disclaimer